---
figid: PMC9618966__fimmu-13-1012002-g006
figtitle: Macrophage scavenger receptor 1 (MSR1) in inflammatory disorders and cancer
organisms:
- NA
organisms_ner:
- Homo sapiens
pmcid: PMC9618966
filename: fimmu-13-1012002-g006.jpg
figlink: /pmc/articles/PMC9618966/figure/f6/
number: F6
caption: Signalling pathways downstream of MSR1 initiated after specific ligand binding.
  Question marks within the figure highlight gaps in the knowledge regarding each
  pathway.
papertitle: The role of macrophage scavenger receptor 1 (MSR1) in inflammatory disorders
  and cancer.
reftext: Jack Gudgeon, et al. Front Immunol. 2022;13:1012002.
year: '2022'
doi: 10.3389/fimmu.2022.1012002
journal_title: Frontiers in Immunology
journal_nlm_ta: Front Immunol
publisher_name: Frontiers Media S.A.
keywords: MSR1 | CD204 | macrophages | immunology | cancer | inflammation
automl_pathway: 0.9597359
figid_alias: PMC9618966__F6
figtype: Figure
redirect_from: /figures/PMC9618966__F6
ndex: ''
seo: CreativeWork
schema-jsonld:
  '@context': https://schema.org/
  '@id': https://pfocr.wikipathways.org/figures/PMC9618966__fimmu-13-1012002-g006.html
  '@type': Dataset
  description: Signalling pathways downstream of MSR1 initiated after specific ligand
    binding. Question marks within the figure highlight gaps in the knowledge regarding
    each pathway.
  license: CC0
  name: CreativeWork
  creator:
    '@type': Organization
    name: WikiPathways
  keywords:
  - TLR3
  - TRIM69
  - TICAM1
  - IRF3
  - MYD88
  - HSP90AA1
  - HSP90B1
  - TRAP1
  - HSP90AB1
  - NFKB1
  - RELA
  - RELB
  - REL
  - NFKB2
  - MVP
  - MMVP1
  - MAPK8
  - MAPK9
  - MAPK10
  - CRK
  - MAPK14
  - MAPK1
  - AIMP2
  - GRAP2
  - AHSA1
  - POLDIP2
  - MAPK11
  - MAPK12
  - MAPK13
  - RAC1
  - RNASE1
  - PAK1
  - PAK2
  - PAK3
  - PAK4
  - PAK5
  - PAK6
  - LTA
  - KRAS
  - HRAS
  - NRAS
  - ZHX2
  - ARAF
  - BRAF
  - RAF1
  - MAP2K7
  - MAP2K1
  - MAP2K2
  - EPHB2
  - MAPK3
  - MYC
  - ETS1
  - ETS2
  - FOS
  - FOSB
  - FOSL1
  - FOSL2
  - JUN
  - JUNB
  - JUND
  - Poly I
---
